Target intelligence / Profile preview

Modifier gene RNA

Molecular classification
RNA
01

Overview

The term Modifier gene RNA refers to a broad category of ribonucleic acid transcripts derived from modifier genes, which are genes that alter the phenotypic expression of a separate target gene. These RNAs do not cause a disease state independently but instead influence the severity, age of onset, or progression of a primary genetic condition. In a therapeutic context, targeting modifier gene RNA (e.g., through antisense oligonucleotides or RNA interference) aims to shift the phenotypic outcome of a primary mutation toward a more favorable or less severe clinical presentation. Because this term describes a functional class of molecules rather than a specific, unique molecular entity, it is not considered a canonical therapeutic target in pharmacological databases. Examples of specific targets that fit this description include the SMN2 pre-mRNA in Spinal Muscular Atrophy, where the transcript acts as a modifier for the loss of SMN1.

Other names
Genetic modifier RNAModifier transcript
02

Mechanism of action

Not applicable as this is a general category rather than a specific molecular target.

03

Biological functions

Phenotypic modulationGene expression regulationEpigenetic regulation
04

Disease associations

Genetic disordersRare diseasesCancer
05

Safety considerations

Off-target effectsSystemic toxicity of RNA therapeuticsUnintended phenotypic changes due to complex genetic interactions

Beyond the preview

Go deeper on Modifier gene RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modifier gene RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call